Free Trial

CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume

CNS Pharmaceuticals logo
$0.12 0.00 (0.00%)
(As of 11/20/2024 ET)

CNS Pharmaceuticals Short Interest Data

CNS Pharmaceuticals (CNSP) has a short interest of 1.14 million shares. This marks a 2.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 41.19 million shares to cover all short positions.

Current Short Interest
1,140,000 shares
Previous Short Interest
1,110,000 shares
Change Vs. Previous Month
+2.70%
Dollar Volume Sold Short
$127,224.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
33,450,000 shares
Percentage of Shares Shorted
3.41%
Today's Trading Volume
7,872,809 shares
Average Trading Volume
41,188,320 shares
Today's Volume Vs. Average
19%
Short Selling CNS Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CNSP Short Interest Over Time

CNSP Days to Cover Over Time

CNSP Percentage of Float Shorted Over Time

CNS Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,140,000 shares $127,224.00 +2.7%N/A0.1 $0.11
10/15/20241,110,000 shares $137,862.00 +63.5%N/A0.1 $0.12
9/30/2024679,000 shares $88,609.50 +86.2%N/A0.1 $0.13
9/15/2024364,600 shares $54,033.72 +80.1%N/A0.1 $0.15
8/31/2024202,500 shares $31,833.00 +87.7%N/A0 $0.16
8/15/2024107,900 shares $15,213.90 -90.3%N/A0 $0.14
7/31/20241,110,000 shares $351,648.00 +314.3%40.1%0.3 $0.32
7/15/2024267,900 shares $316,122.00 +229.9%9.7%0.2 $1.18
6/30/202481,200 shares $128,296.00 +29.7%5.8%0.1 $1.58
6/15/202462,600 shares $174,654.00 +1,465.0%27.3%0.2 $2.79
5/31/20244,000 shares $43,240.00 -93.6%1.8%0.2 $10.81
5/15/202462,500 shares $12,006.25 +100.3%0.6%0.2 $0.19
4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21
4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24
3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36
3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36
2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28
2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28
1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25
1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94
12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27
12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73
11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08
11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92
10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07
10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35
9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14
9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50
8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71
8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71
7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26
7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14
6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23
6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16
5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84
5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39
4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51
4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35
3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00
3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85
2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72
1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21
1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40
12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40
12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55
11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03
11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19
10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16
10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20
9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18
9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25
8/31/2022183,300 shares $44,798.52 -1.6%N/A0.3 $0.24
8/15/2022186,200 shares $48,207.18 +17.7%N/A0.3 $0.26
7/31/2022158,200 shares $34,756.54 +870.6%N/A0.3 $0.22
7/15/202216,300 shares $4,401.00 -95.0%N/A0 $0.27
6/30/2022325,800 shares $91,224.00 +15.4%N/A0.4 $0.28
6/15/2022282,400 shares $77,010.48 -46.6%N/A0.3 $0.27
5/31/2022528,500 shares $160,241.20 +80.6%N/A0.6 $0.30
5/15/2022292,600 shares $84,854.00 -19.7%N/A0.2 $0.29
4/30/2022364,500 shares $123,201.00 -9.5%N/A0.2 $0.34
4/15/2022402,800 shares $157,092.00 +1,154.8%N/A0.3 $0.39
3/31/202232,100 shares $10,946.10 -89.0%N/A0 $0.34
3/15/2022291,000 shares $93,120.00 -46.3%1.6%0.2 $0.32
2/28/2022541,900 shares $211,341.00 +41.6%3.1%0.4 $0.39
2/15/2022382,700 shares $133,945.00 -69.9%2.2%0.5 $0.35
1/31/20221,270,000 shares $763,270.00 +8.6%7.2%1.7 $0.60
1/15/20221,170,000 shares $895,050.00 +353.7%6.6%1.6 $0.77
12/31/2021257,900 shares $181,148.96 +8.8%1.5%0.4 $0.70
12/15/2021237,000 shares $218,182.20 -21.5%1.4%1.1 $0.92
11/30/2021301,800 shares $338,016.00 +16.1%1.7%1.4 $1.12
11/15/2021260,000 shares $293,800.00 -19.7%1.5%1.3 $1.13
10/29/2021323,900 shares $446,982.00 -10.8%1.9%2.2 $1.38
10/15/2021363,200 shares $533,904.00 -2.6%2.1%2.7 $1.47
9/30/2021373,000 shares $555,770.00 -16.9%2.2%2.1 $1.49
9/15/2021448,700 shares $695,485.00 +6.9%2.6%0.9 $1.55
8/31/2021419,600 shares $713,320.00 0.0%2.6%0.8 $1.70
8/13/2021419,700 shares $700,899.00 -3.9%2.6%0.8 $1.67
7/30/2021436,900 shares $751,468.00 -28.0%2.9%0.9 $1.72
7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80
6/30/2021385,400 shares $755,384.00 +30.4%2.6%0.8 $1.96
6/15/2021295,600 shares $588,244.00 +1.2%2.0%1.9 $1.99
5/28/2021292,100 shares $540,385.00 -12.7%1.9%1.3 $1.85
5/14/2021334,400 shares $571,824.00 +11.1%2.2%1.2 $1.71
4/30/2021300,900 shares $616,845.00 -4.2%2.0%0.5 $2.05
4/15/2021314,100 shares $669,033.00 -17.0%2.1%0.2 $2.13
3/31/2021378,400 shares $877,888.00 -26.9%2.5%0.2 $2.32
3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67
2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88
2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
1/29/202166,000 shares $119,460.00 -53.2%0.5%0 $1.81
1/15/2021140,900 shares $264,892.00 +13.7%1.0%0.1 $1.88
12/31/2020123,900 shares $219,303.00 +89.7%0.9%0.1 $1.77
12/15/202065,300 shares $158,679.00 -4.3%0.9%0.1 $2.43
11/30/202068,200 shares $163,680.00 -15.0%1.0%1.4 $2.40
11/15/202080,200 shares $170,024.00 +6.5%1.2%1.1 $2.12
10/30/202075,300 shares $134,787.00 -1.3%1.2%0.8 $1.79
10/15/202076,300 shares $144,970.00 -10.7%1.2%0.8 $1.90
9/30/202085,400 shares $150,304.00 -5.6%1.3%0.8 $1.76
9/15/202090,500 shares $177,380.00 -25.6%1.4%0.9 $1.96
8/31/2020121,700 shares $261,655.00 +32.4%1.9%0.9 $2.15
8/14/202091,900 shares $162,663.00 -9.6%1.4%0.9 $1.77
7/31/2020101,600 shares $188,976.00 +19.0%1.6%1.4 $1.86
7/15/202085,400 shares $146,888.00 -15.1%1.3%1.2 $1.72
6/30/2020100,600 shares $215,284.00 -30.6%1.6%0.7 $2.14
6/15/2020144,900 shares $357,903.00 +45.6%2.2%1 $2.47
5/29/202099,500 shares $238,800.00 +22.4%1.5%0.8 $2.40
5/15/202081,300 shares $224,388.00 +4.9%1.3%0.5 $2.76
4/30/202077,500 shares $222,425.00 -29.7%1.2%0.5 $2.87
4/15/2020110,200 shares $360,354.00 +106.8%1.7%0.7 $3.27
3/31/202053,300 shares $148,707.00 -43.0%0.8%0.3 $2.79
3/13/202093,500 shares $312,290.00 +29.5%1.4%0.6 $3.34
2/28/202072,200 shares $173,280.00 +1.4%1.1%0.8 $2.40
2/14/202071,200 shares $250,624.00 -6.9%1.1%1 $3.52
1/31/202076,500 shares $289,935.00 -34.6%1.2%0.7 $3.79
1/15/2020117,000 shares $479,700.00 -19.1%1.8%0.9 $4.10
12/31/2019144,600 shares $636,240.00 No Change3.3%1.1 $4.40

CNSP Short Interest - Frequently Asked Questions

What is CNS Pharmaceuticals' current short interest?

Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,140,000 shares of CNSP short. Learn More on CNS Pharmaceuticals' current short interest.

Is CNS Pharmaceuticals' short interest increasing or decreasing?

CNS Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 1,140,000 shares, an increase of 2.7% from the previous total of 1,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CNS Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to CNS Pharmaceuticals: Cumberland Pharmaceuticals Inc. (0.97%), Tenax Therapeutics, Inc. (3.55%), Cara Therapeutics, Inc. (2.06%), Aprea Therapeutics, Inc. (0.61%), Bright Green Co. (0.89%), Synlogic, Inc. (0.76%), Mannatech, Incorporated (0.19%), Kazia Therapeutics Limited (0.71%), TherapeuticsMD, Inc. (0.26%), IN8bio, Inc. (3.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short CNS Pharmaceuticals stock?

Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CNS Pharmaceuticals?

A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further.

How often is CNS Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CNSP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners